Skip to content
Seoul Market Wire

Korean stocks, the won and the economy

  • KOSPI5,067.44+1.99%
  • KOSDAQ662.81+1.96%
  • USD/KRW1,333.0-0.19%
  • Samsung Elec.194,700+2.31%
  • SK hynix1,144,000+4.19%

KRX close & FX ref. 2026-11-18 (KST)

Stocks

PharmaResearch's cosmetics-led growth squeezes margins as broker targets diverge

Six of eight brokerage reports reviewed cut their targets after third-quarter results. A higher cosmetics share of sales, CG USA acquisition expenses and operating losses weighed on margins.

Commercial bank headquarters and financial towers in Yeouido, Seoul at golden hour.
Commercial bank headquarters and financial towers in Yeouido, Seoul at golden hour. Illustration: Seoul Market Wire

Market data: Korea Exchange regular-session close & Hana Bank USD/KRW reference rate, 2026-11-17 (KST)

Market data chart for PharmaResearch's cosmetics-led growth squeezes margins as broker targets diverge

Sources

  1. Eugene Investment & Securities — 3Q26 Review: Time to focus on profit growth over margins (Nov. 9, 2026) stock.naver.com
  2. Yuanta Securities Korea — Export-led growth as margins pause (Nov. 9, 2026) stock.naver.com
  3. Daishin Securities — The share price has passed its low (Nov. 9, 2026) stock.naver.com
  4. IBK Securities — Time to focus on export-led growth (Nov. 9, 2026) stock.naver.com
  5. Kyobo Securities — 3Q26 Review: The bottom is passing (Nov. 9, 2026) stock.naver.com
3 more sources
  1. Kiwoom Securities — PharmaResearch third-quarter review (descriptive label; Nov. 9, 2026) stock.naver.com
  2. Mirae Asset Securities — PharmaResearch third-quarter review (descriptive label; Nov. 9, 2026) stock.naver.com
  3. Shinhan Securities — Growth confirmed despite concerns (Nov. 9, 2026) stock.naver.com